Recent investigations have increasingly underscored the role of fibrinogen—a key glycoprotein integral to blood coagulation—as a potential independent biomarker in cancer prognosis. Elevated plasma ...
The FDA has approved Fesilty (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency (CFD), including hypo- or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results